166 related articles for article (PubMed ID: 17100777)
1. A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity.
Sakly W; Thomas V; Quash G; El Alaoui S
Clin Exp Immunol; 2006 Dec; 146(3):550-8. PubMed ID: 17100777
[TBL] [Abstract][Full Text] [Related]
2. Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells.
Caputo I; Barone MV; Lepretti M; Martucciello S; Nista I; Troncone R; Auricchio S; Sblattero D; Esposito C
Biochim Biophys Acta; 2010 Sep; 1802(9):717-27. PubMed ID: 20553859
[TBL] [Abstract][Full Text] [Related]
3. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.
Rauhavirta T; Qiao SW; Jiang Z; Myrsky E; Loponen J; Korponay-Szabó IR; Salovaara H; Garcia-Horsman JA; Venäläinen J; Männistö PT; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
Clin Exp Immunol; 2011 Apr; 164(1):127-36. PubMed ID: 21235541
[TBL] [Abstract][Full Text] [Related]
4. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
[TBL] [Abstract][Full Text] [Related]
5. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
6. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
Dieterich W; Esslinger B; Trapp D; Hahn E; Huff T; Seilmeier W; Wieser H; Schuppan D
Gut; 2006 Apr; 55(4):478-84. PubMed ID: 16188922
[TBL] [Abstract][Full Text] [Related]
7. Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells.
Caputo I; Secondo A; Lepretti M; Paolella G; Auricchio S; Barone MV; Esposito C
PLoS One; 2012; 7(9):e45209. PubMed ID: 23049776
[TBL] [Abstract][Full Text] [Related]
8. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Skovbjerg H; Koch C; Anthonsen D; Sjöström H
Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
[TBL] [Abstract][Full Text] [Related]
9. Blocking peptides decrease tissue transglutaminase processing of gliadin in vitro.
Hoffmann K; Alminger M; Andlid T; Chen T; Olsson O; Sandberg AS
J Agric Food Chem; 2009 Nov; 57(21):10150-5. PubMed ID: 19813732
[TBL] [Abstract][Full Text] [Related]
10. Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction.
Diós Á; Elek R; Szabó I; Horváth S; Gyimesi J; Király R; Werkstetter K; Koletzko S; Fésüs L; Korponay-Szabó IR
Amino Acids; 2021 Jul; 53(7):1051-1063. PubMed ID: 34059947
[TBL] [Abstract][Full Text] [Related]
11. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.
Quarsten H; Molberg O; Fugger L; McAdam SN; Sollid LM
Eur J Immunol; 1999 Aug; 29(8):2506-14. PubMed ID: 10458765
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Transglutaminase 2 as a Therapeutic Strategy in Celiac Disease-In Vitro Studies in Intestinal Cells and Duodenal Biopsies.
Stricker S; de Laffolie J; Zimmer KP; Rudloff S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902226
[TBL] [Abstract][Full Text] [Related]
13. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.
Skovbjerg H; Norén O; Anthonsen D; Moller J; Sjöström H
Scand J Gastroenterol; 2002 Jul; 37(7):812-7. PubMed ID: 12190095
[TBL] [Abstract][Full Text] [Related]
14. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity.
van de Wal Y; Kooy Y; van Veelen P; Peña S; Mearin L; Papadopoulos G; Koning F
J Immunol; 1998 Aug; 161(4):1585-8. PubMed ID: 9712018
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa.
Luciani A; Villella VR; Vasaturo A; Giardino I; Pettoello-Mantovani M; Guido S; Cexus ON; Peake N; Londei M; Quaratino S; Maiuri L
Gut; 2010 Mar; 59(3):311-9. PubMed ID: 19951908
[TBL] [Abstract][Full Text] [Related]
16. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides.
Lebreton C; Ménard S; Abed J; Moura IC; Coppo R; Dugave C; Monteiro RC; Fricot A; Traore MG; Griffin M; Cellier C; Malamut G; Cerf-Bensussan N; Heyman M
Gastroenterology; 2012 Sep; 143(3):698-707.e4. PubMed ID: 22750506
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Agardh D
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.
Ankelo M; Kleimola V; Simell S; Simell O; Knip M; Jokisalo E; Tarkia M; Westerlund A; He Q; Viander M; Ilonen J; Hinkkanen AE
Clin Exp Immunol; 2007 Nov; 150(2):285-93. PubMed ID: 17803713
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.
Olen O; Gudjónsdóttir AH; Browaldh L; Hessami M; Elvin K; Liedberg AS; Neovius M; Grahnquist L
J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):695-700. PubMed ID: 22722680
[TBL] [Abstract][Full Text] [Related]
20. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
